Stockscreener 앱 받기
2.13
7.79%
-0.18
시간 외 거래:
2.23
0.10
+4.69%
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Heron Therapeutics (HRTX) Awaits Q1 Earnings Report - GuruFocus
Marshall Wace LLP Cuts Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (HRTX) Projected to Post Earnings on Tuesday - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Adage Capital Partners GP L.L.C. Decreases Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Renaissance Technologies LLC Has $1.82 Million Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by LPL Financial LLC - Defense World
Healthy Upside Potential: Heron Therapeutics Inc (HRTX) - Sete News
American Society of Anesthesiologists Announces Heron Therapeutics as Industry Supporter for Seventh Year | Newswise - Newswise
HRTX stock rated a Buy by Rodman & Renshaw - knoxdaily.com
It would be worthwhile to take a closer look at Heron Therapeutics Inc (HRTX) - uspostnews.com
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Heron Therapeutics Appoints Mark Hensley as COO - TipRanks
Heron Therapeutics Names Mark Hensley as COO - marketscreener.com
Heron Therapeutics Strengthens Leadership: Former Veloxis CEO Takes COO Role with Major Stock Package - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Heron Therapeutics (NASDAQ:HRTX) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Geode Capital Management LLC Sells 30,034 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Investor’s Delight: Heron Therapeutics Inc (HRTX) Closes Strong at 1.88, Up 6.21 - DWinneX
Financial Metrics Exploration: Understanding Heron Therapeutics Inc (HRTX) Through Ratios - DWinneX
The growth track for Heron Therapeutics Inc (HRTX) has changed recently - Sete News
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Zacks Investment Research
A Closer Look at Heron Therapeutics Inc (HRTX) Stock Gains - investchronicle.com
Is HRTX’s price to cash per share ratio a concern for investors? - uspostnews.com
Heron Therapeutics (NASDAQ:HRTX) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
Heron Therapeutics Sets Key Q1 2025 Earnings Date: What Investors Should Watch on May 6 - Stock Titan
Best Momentum Stocks to Buy for April 22nd - TradingView
Are Medical Stocks Lagging Encompass Health (EHC) This Year? - Yahoo Finance
Lacklustre Performance Is Driving Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 26% Price Drop - simplywall.st
Quinn Opportunity Partners LLC Acquires New Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Takes $208,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World
Raymond James Financial Inc. Takes Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Needham Keeps Their Buy Rating on Heron Therapeutics (HRTX) - The Globe and Mail
Exploring High Growth Tech Stocks In The US Market April 2025 - Yahoo
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - simplywall.st
0.39%
3.66%
자본화:
|
볼륨(24시간):